The Role of Metabolic Syndrome in Endometrial Cancer: A Review
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Endometrial cancer is one of the most common cancers of the female reproductive system. Although surgery, radiotherapy, chemotherapy, and hormone therapy can significantly improve the survival of patients, the treatment of patients with very early lesions and a strong desire to retain reproductive function or late recurrence is still in the early stages. Metabolic syndrome (MS) is a clustering of at least three of the five following medical conditions: central obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein (HDL). Obesity, diabetes and hypertension often coexist in patients with endometrial cancer, which increases the risk of endometrial cancer, also known as the "triple syndrome of endometrial cancer." In recent years, epidemiological and clinical studies have found that MS associated with metabolic diseases is closely related to the incidence of endometrial cancer. However, the key molecular mechanisms underlying the induction of endometrial cancer by MS have not been elucidated to date. Characterizing the tumor metabolism microenvironment will be advantageous for achieving a comprehensive view of the molecular mechanism of metabolic syndrome associated with endometrial cancer and for providing a new target for the treatment of endometrial cancer. This review focuses on recent advances in determining the role of metabolic syndrome-related factors and mechanisms in the pathogenesis of endometrial cancer. We suggest that interfering with the tumor metabolic microenvironment-related molecular signals may inhibit the occurrence of endometrial cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625 · cited 1×
“These pro-inflammatory cytokines can further enhance the infiltration of inflammatory cells, mainly macrophages and T lymphocytes, thereby promoting abnormal proliferation and transformation of normal cells (85).”
BackgroundOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., & Darai, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00130-0 · Cited by 1,514
AMPK: Sensing Glucose as well as Cellular Energy Status
Lin, S.-C., & Hardie, D. G. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.009 · Cited by 1,191 · cited 1×
“AMPK, an adenylateactivated protein kinase, is a key protein for the perception of extracellular glucose concentration (94).”
BackgroundWang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Mechanisms of insulin resistance in obesity
Ye, J. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0262-6 · Cited by 699 · cited 1×
“There are a large number of inflammatory mediators, such as C-reactive protein (CRP), interleukin-6 (IL-6), and plasminogen activator inhibitor-1 (PAI-1), that are elevated in the plasma of obese patients or animals and are closely related to insulin resistance (25).”
BackgroundDiabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
IGF binding proteins in cancer: mechanistic and clinical insights
Baxter, R. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3720 · Cited by 525
Thigpen, J. T., Brady, M. F., Alvarez, R. D., Adelson, M. D., Homesley, H. D., Manetta, A., Soper, J. T., & Given, F. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1736 · Cited by 484
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Bohn, T., Rapp, S., Luther, N., Klein, M., Bruehl, T.-J., Kojima, N., Aranda Lopez, P., Hahlbrock, J., Muth, S., Endo, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0226-8 · Cited by 436 · cited 1×
“Recent studies have found that lactic acid produced by glycolysis of cancer cells can inhibit the function of macrophages through a hypoxia-inducible factor-mediated mechanism, induce the transformation of anti-tumor type M1 macrophages into M2, and promote the invasion and migration of cancer cells (97).”
BackgroundHepatocytes direct the formation of a pro-metastatic niche in the liver
Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1004-y · Cited by 402 · cited 1×
“A new study confirms that blocking IL-6-driven inflammatory signaling can inhibit the spread of cancer cells to the liver (75).”
BackgroundCantrell, L. A., Zhou, C., Mendivil, A., Malloy, K. M., Gehrig, P. A., & Bae-Jump, V. L. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.09.024 · Cited by 331 · cited 1×
“Metformin can significantly inhibit the proliferation of endometrial cancer cells, which may be related to the activation of AMPK signaling and the inhibition of the mTOR signaling pathway (110).”
BackgroundBody mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis
Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M., & Renehan, A. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0832 · Cited by 321
Wei, Y., Wang, D., Jin, F., Bian, Z., Li, L., Liang, H., Li, M., Shi, L., Pan, C., Zhu, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms14041 · Cited by 315 · cited 1×
“Overexpression of PKM2 could promote the accumulation of glycolysis intermediates (pyruvate and lactic acid), provide precursors for the synthesis of biomacromolecules, and lead to cell proliferation and tumorigenesis (96).”
BackgroundProtection of mitochondria prevents high-fat diet–induced glomerulopathy and proximal tubular injury
Szeto, H. H., Liu, S., Soong, Y., Alam, N., Prusky, G. T., & Seshan, S. V. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.013 · Cited by 293 · cited 1×
“The level of the proinflammatory cytokine TGF-α in adipose tissue of obese mice was significantly increased, which was closely related to insulin resistance (24).”
BackgroundLeptin Metabolically Licenses T Cells for Activation To Link Nutrition and Immunity
Saucillo, D. C., Gerriets, V. A., Sheng, J., Rathmell, J. C., & MacIver, N. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301158 · Cited by 282 · cited 1×
“It has been found that adipose tissue-derived leptin can promote the differentiation of Th17 cells and promote T cell function by regulating cell metabolic reprogramming (87).”
BackgroundUnderstanding obesity and endometrial cancer risk: opportunities for prevention
Schmandt, R. E., Iglesias, D. A., Co, N. N., & Lu, K. H. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.05.042 · Cited by 268
Wang, Y., Xu, W., Yan, Z., Zhao, W., Mi, J., Li, J., & Yan, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0731-5 · Cited by 254 · cited 1×
“AMPK phosphorylation also plays an important role in energy metabolism by activating the TSC2 tumor suppressor (49, 50).”
BackgroundLiu, N., Luo, J., Kuang, D., Xu, S., Duan, Y., Xia, Y., Wei, Z., Xie, X., Yin, B., Chen, F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123027 · Cited by 239
Self-citationUSA endometrial cancer projections to 2030: should we be concerned?
Sheikh, M. A., Althouse, A. D., Freese, K. E., Soisson, S., Edwards, R. P., Welburn, S., Sukumvanich, P., Comerci, J., Kelley, J., LaPorte, R. E., et al. (2014) · Future Oncology · doi:10.2217/fon.14.192 · Cited by 236 · cited 1×
“13 per 100,000 people in the United States by 2030 (2).”
BackgroundRole of Progesterone in Endometrial Cancer
Kim, J., & Chapman-Davis, E. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242998 · Cited by 213 · cited 1×
“However, the overall effective rate of progesterone therapy for primary endometrial cancer is only 50–70%, and the recurrence rate is as high as 40% (5, 6).”
BackgroundCritical role of AMPK in redox regulation under glucose starvation
Ren, Y., & Shen, H.-M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101154 · Cited by 193 · cited 1×
“AMPK phosphorylation also plays an important role in energy metabolism by activating the TSC2 tumor suppressor (49, 50).”
BackgroundNead, K. T., Sharp, S. J., Thompson, D. J., Painter, J. N., Savage, D. B., Semple, R. K., Barker, A., Perry, J. R. B., Attia, J., Dunning, A. M., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv178 · Cited by 182
Insulin resistance: A significant risk factor of endometrial cancer
Mu, N., Zhu, Y., Wang, Y., Zhang, H., & Xue, F. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.03.032 · Cited by 182 · cited 2×
“The expression of insulin and IGF-1 was significantly increased in diabetic patients, and high insulin levels were an independent factor of endometrial cancer (28, 101, 102).”
BackgroundTrabert, B. L., Wentzensen, N., Felix, A. S., Yang, H., Sherman, M. E., & Brinton, L. A. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0923 · Cited by 180 · cited 1×
“However, the exact mechanism of metabolic syndrome affecting the occurrence and development of endometrial cancer has not been determined to date, which may be related to the elevation of such metabolites as blood sugar, insulin, insulin-like growth factor and triglyceride in serum (14, 15).”
BackgroundMetabolic syndrome and endometrial cancer: a meta-analysis
Esposito, K., Chiodini, P., Capuano, A., Bellastella, G., Maiorino, M. I., & Giugliano, D. (2014) · Endocrine · doi:10.1007/s12020-013-9973-3 · Cited by 179
Inflammation during obesity is not all bad: evidence from animal and human studies
Ye, J., & McGuinness, O. P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2012 · Cited by 174
CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer
Zhong, X.-Y., Yuan, X.-M., Xu, Y.-Y., Yin, M., Yan, W.-W., Zou, S.-W., Wei, L.-M., Lu, H.-J., Wang, Y.-P., & Lei, Q.-Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.066 · Cited by 158 · cited 1×
“It was reported that high extracellular glucose levels regulate the protein level of CARM1 by reducing AMPK phosphorylation, thereby inhibiting GAPDH methylation, which further promotes the activity of the GAPDH enzyme and glycolysis pathway (95).”
BackgroundHao, J., Zhang, Y., Yan, X., Yan, F., Sun, Y., Zeng, J., Waigel, S., Yin, Y., Fraig, M. M., Egilmez, N. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.006 · Cited by 158 · cited 1×
“It has been reported that A-FABP released from adipose tissue can promote the dryness and invasiveness of breast cancer cells (119).”
BackgroundHe, Y., Cai, B., Yang, Y., Liu, X., & Wan, X. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01148.x · Cited by 157 · cited 1×
“In addition, estrogen can promote the expression of IL-6 in endometrial cancer cells by binding to GPER on the cell surface (73).”
BackgroundMacKintosh, M. L., Derbyshire, A. E., McVey, R. J., Bolton, J., Nickkho‐Amiry, M., Higgins, C. L., Kamieniorz, M., Pemberton, P. W., Kirmani, B. H., Ahmed, B., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31913 · Cited by 135 · cited 1×
“It was found that insulin resistance (HbA1c, HOMA-IR) and inflammation (hsCRP, IL-6) circulating biomarkers decreased, while reproductive biomarkers (LH, FSH, SHBG) increased significantly (125).”
BackgroundMetformin use and endometrial cancer survival
Nevadunsky, N. S., Van Arsdale, A., Strickler, H. D., Moadel, A., Kaur, G., Frimer, M., Conroy, E., Goldberg, G. L., & Einstein, M. H. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.10.026 · Cited by 133 · cited 1×
“In contrast, some studies have shown that metformin does not reduce the risk of endometrial cancer, nor can it improve the overall survival of patients (111).”
ResultDieli-Conwright, C. M., Parmentier, J., Sami, N., Lee, K., SPICER, D. V., Mack, W. J., Sattler, F. R., & Mittelman, S. D. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4576-y · Cited by 131
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
Zhang, H., Fagan, D. H., Zeng, X., Freeman, K. T., Sachdev, D., & Yee, D. (2010) · Oncogene · doi:10.1038/onc.2010.17 · Cited by 130 · cited 1×
“In addition, insulin could upregulate the expression of vascular endothelial growth factor, thereby stimulating angiogenesis, which is closely related to the occurrence and development of tumors (106).”
BackgroundObesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
Kolb, R., Kluz, P., Tan, Z. W., Borcherding, N., Bormann, N., Vishwakarma, A., Balcziak, L., Zhu, P., Davies, B. S., Gourronc, F., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0592-6 · Cited by 123 · cited 1×
“Recent studies have shown that obesity can increase the infiltration of tumor-related macrophages, upregulate the production of IL-1β, and promote angiogenesis and tumor progression (88).”
BackgroundStrong, A. L., Strong, T. A., Rhodes, L. V., Semon, J. A., Zhang, X., Shi, Z., Zhang, S., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2013) · Breast Cancer Research · doi:10.1186/bcr3569 · Cited by 119 · cited 1×
“Leptin secreted by adipose-derived stem cells promotes the growth and metastasis of ER+ breast cancer by increasing the expression of ER receptor and aromatase (39).”
BackgroundMadak-Erdogan, Z., Band, S., Zhao, Y. C., Smith, B. P., Kulkoyluoglu-Cotul, E., Zuo, Q., Santaliz Casiano, A., Wrobel, K., Rossi, G., Smith, R. L., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2849 · Cited by 114 · cited 1×
“Moreover, recent studies have found that elevated circulating free fatty acidsmay be an important factor in linking obesity and tumorigenesis, which can promote the proliferation and invasion of breast cancer cells through ERα signaling and the mTOR signaling pathway (118).”
BackgroundLiu, Z., Wang, N., Ma, Y., & Wen, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00390 · Cited by 108 · cited 1×
“expression of insulin receptor substrate 1 (IRS-1) and insulin receptor (IR) in insulin signaling pathways and inhibition of PPAR gamma function, and ultimately leads to insulin resistance (26, 27).”
BackgroundBariatric surgery decreases the risk of uterine malignancy
Ward, K. K., Roncancio, A. M., Shah, N. R., Davis, M. A., Saenz, C. C., McHale, M. T., & Plaxe, S. C. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.11.012 · Cited by 100 · cited 1×
“A study reported that a history of bariatric surgery and maintained normal weight after surgery is associated with a 71 and 81% reduced risk for uterine malignant tumors (19).”
BackgroundGu, S., Ni, T., Wang, J., Liu, Y., Fan, Q., Wang, Y., Huang, T., Chu, Y., Sun, X., & Wang, Y. (2018) · Journal of Immunology Research · doi:10.1155/2018/6156757 · Cited by 98 · cited 1×
“Interestingly, M2 macrophages are the predominant tumor-associated macrophages in endometrial cancer and play an important role in the occurrence and development of endometrial cancer (98).”
BackgroundSelf-citationKitson, S., Evans, D. G., & Crosbie, E. J. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0224 · Cited by 97
Ahmad, R., Al-Roub, A., Kochumon, S., Akther, N., Thomas, R., Kumari, M., Koshy, M., Tiss, A., Hannun, Y. A., Tuomilehto, J., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701552 · Cited by 95
Nagle, C. M., Crosbie, E. J., Brand, A. H., Obermair, A., Oehler, M. K., Quinn, M. A., Leung, Y. C., Spurdle, A. B., & Webb, P. M. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.04.006 · Cited by 93
Impact of obesity on breast cancer recurrence and minimal residual disease
Ecker, B. L., Lee, J. Y., Sterner, C. J., Solomon, A. C., Pant, D. K., Shen, F., Peraza, J., Vaught, L. A., Mahendra, S., Belka, G. K., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-018-1087-7 · Cited by 89 · cited 1×
“Some scholars have confirmed the causal relationship between obesity and breast cancer by constructing a genetically engineered mouse model and have shown that obesity is closely related to the increase in the survival rate of residual cancer cells (17).”
BackgroundMetabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study
Arthur, R., Kabat, G. C., Kim, M., Wild, R. A., Shadyab, A. H., Wactawski‐Wende, J., Ho, G. Y. F., Reeves, K. W., Kuller, L. H., Luo, J., et al. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01139-5 · Cited by 88
Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients
López, J. S. J., Tejerizo-García, A., Muñoz-González, J. L., Sotillos, S. B., Marques, L. M., González, G. L., & Gómez, J. F. P.-R. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s51532 · Cited by 87
Obesity‐driven endometrial cancer: is weight loss the answer?
MacKintosh, M. L., & Crosbie, E. J. (2013) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12106 · Cited by 86 · cited 1×
“indicated obese undergoing bariatric surgery or medical weight loss management could reduce the risk of endometrial cancer and hyperplastic abnormalities of the endometrium may be reversible through weight loss (124).”
BackgroundAlipourfard, I., Datukishvili, N., & Mikeladze, D. (2019) · Mediators of Inflammation · doi:10.1155/2019/3560819 · Cited by 82
Ning, C., Xie, B., Zhang, L., Li, C., Shan, W., Yang, B., Luo, X., Gu, C., He, Q., Jin, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1260 · Cited by 82
Hao, J., Bao, X., Jin, B., Wang, X., Mao, Z., Li, X., Wei, L., Shen, D., & Wang, J. (2015) · The FASEB Journal · doi:10.1096/fj.14-265603 · Cited by 80
Self-citationKheirandish, M., Mahboobi, H., Yazdanparast, M. S., Kamal, W., & Kamal, M. A. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180416161846 · Cited by 80
Dynamic Metabolomics Reveals that Insulin Primes the Adipocyte for Glucose Metabolism
Krycer, J. R., Yugi, K., Hirayama, A., Fazakerley, D. J., Quek, L., Scalzo, R. A., Ohno, S., Hodson, M. P., Ikeda, S., Shoji, F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.085 · Cited by 80 · cited 1×
“Recent studies have reported that insulin signal-dependent phosphorylation initiates glucose metabolism prior to glucose transport; thus, the metabolism of glucose is diverted to a specific direction of glycolysis (107).”
BackgroundStrong, A. L., Pei, D. T., Hurst, C. G., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2017) · Stem Cells International · doi:10.1155/2017/9216502 · Cited by 77 · cited 1×
“Obesity can promote the transformation of adipose-derived stem cells (ASCs) into cancer-related fibroblasts (CAFs), thereby promoting the proliferation and invasive phenotype of cancer cells (37).”
BackgroundActivation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Chen, J., Zhao, K., Li, R., Shao, R., & Chen, C. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140414095605 · Cited by 77 · cited 1×
“A new bidirectional inhibitor of PI3K andmTOR ismore effective than a simple inhibitor of mTOR (rapamycin) in inhibiting endometrial cancer (36).”
BackgroundTumor necrosis factor (TNF)‐α, soluble TNF receptors and endometrial cancer risk: The EPIC study
Dossus, L., Becker, S., Rinaldi, S., Lukanova, A., Tjønneland, A., Olsen, A., Overvad, K., Chabbert‐Buffet, N., Boutron‐Ruault, M., Clavel‐Chapelon, F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25840 · Cited by 75
Moon, H., Chamberland, J. P., Aronis, K. N., Tseleni‐Balafouta, S., & Mantzoros, C. S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0545 · Cited by 75 · cited 1×
“Adiponectin/AdipoRs can inhibit the proliferation, adhesion and invasiveness of endometrial cancer cells by activating the downstream LKB1-AMPK/S6 signal axis (51).”
BackgroundWang, Y., Gao, C., Zhang, Y., Gao, J., Teng, F., Tian, W., Yang, W., Yan, Y., & Xue, F. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.109 · Cited by 74 · cited 1×
“Studies have shown that visfatin can upregulate the expression of IR and insulin receptor substrate (IRS) 1/2, and it can coactivate the PI3K/Akt and MAPK/ERK1/2 signaling pathways with insulin to promote the proliferation and inhibit apoptosis of endometrial cancer cells (59).”
BackgroundChe, Q., Liu, B., Liao, Y. J., Zhang, H., Yang, T., He, Y., Xia, Y., Lu, W., He, X., Chen, Z., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28679 · Cited by 73
Free fatty acid concentrations correlated with the available fraction of estradiol in human plasma.
Bruning, P. F., & Bonfrèr, J. M. G. (1986) · PubMed · Cited by 69
Zahid, H., Subbaramaiah, K., Iyengar, N. M., Zhou, X. K., Chen, I., Bhardwaj, P., Gucalp, A., Morrow, M., Hudis, C. A., Dannenberg, A. J., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.273 · Cited by 68
Kamanga‐Sollo, E., White, M. E., Hathaway, M. R., Chung, K. Y., Johnson, B. J., & Dayton, W. R. (2008) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2008.02.003 · Cited by 67
Ko, J., Um, J., Lee, S., Yang, W. M., Sethi, G., & Ahn, K. S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28456 · Cited by 67 · cited 1×
“Adipose tissue mesenchymal stem cell-derived medium can activate Akt/mTOR and promote the proliferation and invasion of cancer cells (35).”
BackgroundKitson, S., Maskell, Z., Sivalingam, V. N., Allen, J. L., Ali, S., Burns, S., Gilmour, K., Latheef, R., Slade, R. J., Pemberton, P. W., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3339 · Cited by 63
Kitson, S., Lindsay, J., Sivalingam, V. N., Lunt, M., Ryan, N. A. J., Edmondson, R. J., Rutter, M. K., & Crosbie, E. J. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.11.019 · Cited by 63 · cited 1×
“A prospective case control study reported that women newly diagnosed with endometrial cancer have a higher prevalence of incident hyperglycemia, total: HDL cholesterol ratio, and three or more cardiovascular risk factors than women without endometrial cancer (13).”
BackgroundPulmonary Hypertension and Obesity: Focus on Adiponectin
Perrotta, F., Nigro, E., Mollica, M., Costigliola, A., D’Agnano, V., Daniele, A., Bianco, A., & Guerra, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040912 · Cited by 59
An IL-6 link between obesity and cancer
Ghosh, S. (2013) · Frontiers in Bioscience · doi:10.2741/e628 · Cited by 57 · cited 1×
“The elevated plasma level of IL-6 is closely related to the poor prognosis of tumors (72).”
BackgroundGu, C., Xie, F., Zhang, B., Yang, H., Cheng, J., He, Y., Zhu, X., Li, D., & Li, M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494237 · Cited by 57 · cited 1×
“It has been reported that high glucose could promote the expression of vascular endothelial growth factor (VEGF)/VEGFR and the process of (epithelial-mesenchymal transition) EMT by regulating the expression of ERα/GLUT4, thereby promoting the proliferation and invasion of endometrial cancer cells (92).”
BackgroundThe clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma
Smith, H. O., Stephens, N. D., Qualls, C. R., Fligelman, T., Wang, T., Lin, C.-Y., Burton, E., Griffith, J. K., & Pollard, J. W. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.002 · Cited by 56 · cited 1×
“The level of TNFα in circulating blood of obese patients is increased, and the increased level of TNF-α is closely related to the poor prognosis of endometrial cancer patients (76).”
BackgroundNigro, E., Schettino, P., Polito, R., Scudiero, O., Monaco, M. L., Palma, G. D. D., & Daniele, A. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3319-7 · Cited by 54
Circulating visfatin levels and cancers risk: A systematic review and meta‐analysis
Mohammadi, M., Mianabadi, F., & Mehrad‐Majd, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27302 · Cited by 53
Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation
Liu, Y., Lv, L., Xiao, W., Gong, C., Yin, J., Wang, D., & Sheng, H. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0382-7 · Cited by 53 · cited 1×
“Correspondingly, this proliferation is inhibited when the JAK/STAT3 pathway is blocked (66).”
BackgroundChu, Y., Wang, Y., Peng, W., Xu, L., Liu, M., Li, J., Hu, X., Li, Y., Zuo, J., & Ye, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.121 · Cited by 52 · cited 1×
“Adipose-derived IL-6 can promote the proliferation, invasion and angiogenesis of endometrial cancer cells by activating the JAK/STAT3 signaling pathway (71).”
BackgroundCherry, N., McNamee, R., Heagerty, A. M., Kitchener, H. C., & Hannaford, P. C. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12598 · Cited by 52
Tang, H., Liao, Y., Xu, L., Zhang, C., Liu, Z., Deng, Y., Jiang, Z., Fu, S., Chen, Z., & Zhou, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28262 · Cited by 51 · cited 1×
“Studies have found that estrogen and IGF-1 can synergistically promote the development of tumors in mice by activating MAPK and AKT signaling pathways (32).”
BackgroundMonocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
Latif, A., Chadwick, A. L., Kitson, S., Gregson, H. J., Sivalingam, V. N., Bolton, J., McVey, R. J., Roberts, S. A., Marshall, K. M., Williams, K. J., et al. (2017) · BMC Clinical Pathology · doi:10.1186/s12907-017-0067-7 · Cited by 50 · cited 1×
“It has been reported that MCT1 was an independent prognostic biomarker in endometrial cancer (99).”
BackgroundHigh Leptin Level is an Independent Risk Factor of Endometrial Cancer: A Meta-Analysis
Wang, P., He, X., Wang, R., Wang, Z., & Wang, Y.-G. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366352 · Cited by 49
The impact of 27-hydroxycholesterol on endometrial cancer proliferation
Gibson, D. A., Collins, F., Cousins, F. L., Esnal‐Zufiaurre, A., & Saunders, P. T. K. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0449 · Cited by 48 · cited 1×
“Cholesterol activates the transcriptional activity of endometrial cancer cells through an ER-dependent pathway and promotes the proliferation of endometrial cancer cells (117).”
BackgroundEndometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort
Fortner, R. T., Hüsing, A., Kuhn, T. E., Konar, N. M., Overvad, K., Tjønneland, A. M., Hansen, L., Boutron‐Ruault, M., Severi, G., Fournier, A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30560 · Cited by 47
Tenvooren, I., Jenks, M. Z., Rashid, H., Cook, K. L., Mühlemann, J. K., Sistrunk, C., Holmes, J., Wang, K., Bonin, K., Hodges, K. B., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0687-8 · Cited by 46 · cited 1×
“Elevated leptin levels can influence epithelial polarity and promote malignant transformation through overactivation of the PI3K/Akt signaling pathway (65).”
BackgroundCase–control study of markers of insulin resistance and endometrial cancer risk
Friedenreich, C. M., Langley, A. R., Speidel, T. P., Lau, D. C. W., Courneya, K. S., Csizmadi, I., Magliocco, A. M., Yasui, Y., & Cook, L. S. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0211 · Cited by 46 · cited 1×
“The expression of insulin and IGF-1 was significantly increased in diabetic patients, and high insulin levels were an independent factor of endometrial cancer (28, 101, 102).”
BackgroundSahoo, S. S., Lombard, J. M., Ius, Y., O’Sullivan, R., Wood, L. G., Nahar, P., Jaaback, K., & Tanwar, P. S. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0466 · Cited by 46
Sayeed, M., Gautam, S., Verma, D. P., Afshan, T., Kumari, T., Srivastava, A. K., & Ghosh, J. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001801 · Cited by 45 · cited 1×
“improving the metabolism of glucose and fatty acids (53).”
BackgroundWallbillich, J. J., Josyula, S., Saini, U., Zingarelli, R. A., Dorayappan, K. D. P., Riley, M., Wanner, R. A., Cohn, D. E., & Selvendiran, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170318 · Cited by 45
Kabat, G. C., Kim, M., Lane, D. S., Zaslavsky, O., Ho, G. Y. F., Luo, J., Nicholson, W. K., Chlebowski, R. T., Barrington, W. E., Vitolins, M. Z., et al. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000435 · Cited by 44 · cited 1×
“The expression of insulin and IGF-1 was significantly increased in diabetic patients, and high insulin levels were an independent factor of endometrial cancer (28, 101, 102).”
BackgroundSteiner, E., Pollow, K., Hasenclever, D., Schormann, W., Hermes, M., Schmidt, M., Puhl, A. G., Brulport, M., Bauer, A., Petry, I. B., et al. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.11.025 · Cited by 44 · cited 1×
“PAI-1 is highly expressed in endometrial cancer tissues and is closely related to the poor prognosis of endometrial cancer (83).”
BackgroundDifferent molecular signaling sustaining adiponectin action in breast cancer
Panno, M. L., Naimo, G. D., Spina, E., Andò, S., & Mauro, L. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.08.001 · Cited by 43 · cited 1×
“AdipoR1 is mainly expressed in skeletal muscle and epithelial cells, and AdipoR2 is most abundant in the liver (48).”
BackgroundCirculating Serum Level of Visfatin in Patients with Endometrial Cancer
Cymbaluk‐Płoska, A., Chudecka-Glaz, A. M., Pius‐Sadowska, E., Sompolska‐Rzechuła, A., Machaliński, B., & Menkiszak, J. (2018) · BioMed Research International · doi:10.1155/2018/8576179 · Cited by 43
Zhang, Y., Liu, L., Li, C., & Ai, H. (2014) · Cancer Biomarkers · doi:10.3233/cbm-140415 · Cited by 42 · cited 1×
“The elevated expression of leptin and ObR is closely related to lymph node metastasis and poor survival prognosis, as well as the positive expression of ERs (64).”
BackgroundEstrogen and insulin synergistically promote type 1 endometrial cancer progression
Tian, W., Teng, F., Zhao, J. T., Gao, J., Gao, C., Sun, D., Liu, G., Zhang, Y., Yu, S., Zhang, W., et al. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1394547 · Cited by 42 · cited 1×
“Studies have shown that estrogen combined with insulin can significantly promote the proliferation of endometrial cancer cells compared with estrogen or insulin alone (29).”
BackgroundLinkov, F., Goughnour, S. L., Ma, T., Xu, Z., Edwards, R. P., Lokshin, A. E., Ramanathan, R. C., Hamad, G. G., McCloskey, C., & Bovbjerg, D. H. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.07.144 · Cited by 41 · cited 1×
“C-peptide, insulin, C-reactive protein, leptin, IL-1Ralpha, and IL-6 decreased significantly, while SHBG, IGFBP1, and adiponectin increased significantly in weight-loss interventions in endometrial cancer (126).”
BackgroundAdiponectin as a Potential Therapeutic Target for Prostate Cancer
Karnati, H. K., Panigrahi, M. K., Li, Y., Tweedie, D., & Greig, N. H. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170208123553 · Cited by 41
Adiponectin and Endometrial Cancer: A Systematic Review and Meta-Analysis
Zeng, F., Shi, J., Long, Y., Tian, H., Li, X., Zhao, A. Z., Li, R. F., & Chen, T. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430327 · Cited by 40
Dibaba, D. T., Judd, S. E., Gilchrist, S. C., Cushman, M., Pisu, M., Safford, M. M., & Akinyemiju, T. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.007 · Cited by 40
Kim, J. H., Lee, E., Friedline, R. H., Suk, S., Jung, D. Y., Dağdeviren, S., Hu, X., Inashima, K., Noh, H. L., Kwon, J. Y., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701017r · Cited by 39 · cited 1×
“Recently, studies have reported that endoplasmic reticulum chaperone 78 (GRP78) plays an important role in obesity-induced insulin resistance by regulating macrophages (23).”
BackgroundRelationship between Hypothyroidism and Endometrial Cancer
Wang, Y., Zhou, R., & Wang, J. (2018) · Aging and Disease · doi:10.14336/ad.2018.0224 · Cited by 37 · cited 1×
“Hypothyroidism may promote the occurrence and development of endometrial cancer by indirectly increasing the risk factors of endometrial cancer or through direct interaction (123).”
BackgroundSelf-citationSong, N.-Y., Lee, Y.-H., Na, H.-K., Baek, J.-H., & Surh, Y.-J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.001 · Cited by 36
Adipokines as therapeutic targets in breast cancer treatment
Cha, Y. J., & Koo, J. S. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1538356 · Cited by 36
IL‐10 suppresses TNF‐α‐induced expression of human aromatase gene in mammary adipose tissue
Martínez‐Chacón, G., Brown, K. A., Docanto, M. M., Kumar, H., Salminen, S., Saarinen, N., & Mäkelä, S. (2018) · The FASEB Journal · doi:10.1096/fj.201700938rrr · Cited by 35
Sabol, R. A., Beighley, A., Giacomelli, P., Wise, R. M., Harrison, M. A. A., O’Donnnell, B. A., Sullivan, B. N., Lampenfeld, J. D., Matossian, M. D., Bratton, M. R., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061419 · Cited by 33
İlhan, T. T., Kebapçılar, A., Yılmaz, S. A., Ilhan, T. S., Kerimoğlu, Ö. S., Pekin, A. T., Akyürek, F., Ünlü, A., & Çelık, Ç. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.11.4503 · Cited by 33 · cited 1×
“A high level of visfatin suggests poor prognosis in patients with endometrial cancer, which may be a potential therapeutic target for endometrial cancer (57, 58).”
BackgroundShinkov, A. D., Borissovа, A.-M., Kovatcheva, R. D., Atanassova, I., Vlahov, J. D., & Dakovska, L. N. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003538 · Cited by 33 · cited 1×
“Additionally, elevated TSH levels have been reported to increase the incidence of MS (122).”
BackgroundVousden, K. A., Lundqvist, T., Popovic, B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38842-x · Cited by 31 · cited 1×
“Recent studies have found that PAI1 not only plays an important role in influencing insulin signaling but also plays an important biological role in influencing the invasion, invasion and metastasis of obesity-related tumors (82).”
BackgroundRelationships of uterine and ovarian tumors to pre-existing chronic conditions
Brinton, L. A., Sakoda, L. C., Frederiksen, K., Sherman, M. E., Kjær, S. K., Graubard, B. I., Olsen, J. H., & Mellemkjær, L. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.002 · Cited by 31
TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation
Xie, B., Lv, Q., Ning, C., Yang, B., Shan, W., Cheng, Y., Gu, C., Luo, X., Zhang, Z., Chen, X., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.124 · Cited by 29
Modulatory effects of adiponectin on the polarization of tumor-associated macrophages
Peng, J., Tsang, J. Y., Ho, D., Zhang, R., Xiao, H., Li, D., Zhu, J. J., Wang, F., Bian, Z., Lui, V. C. H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29485 · Cited by 28 · cited 1×
“In contrast, it has been reported that the deletion of adiponectin may promote the transformation of M2 tumor-associated macrophages to M1 type through the p38MAPK signaling pathway, thereby inhibiting the growth of tumors (54).”
BackgroundRole of the tumor microenvironment in digestive neuroendocrine tumors
Cuny, T., de Herder, W. W., Barlier, A., & Hofland, L. J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0025 · Cited by 22 · cited 1×
“An abnormal imbalance of the cell microenvironment often leads to tumorigenesis (16).”
BackgroundSeebacher, V., Hofstetter, G., Polterauer, S., Reinthaller, A., Grimm, C., Schwameis, R., Taucher, S., Wagener, A., Marth, C., & Concin, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.282 · Cited by 22 · cited 1×
“Serum TSH level before treatment is an independent risk factor for poor prognosis of EC (121).”
BackgroundLi, M., Li, X., Zhao, L., Zhou, J., Cheng, Y., Xu, B., Wang, J., & Wei, L. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1568743 · Cited by 21 · cited 1×
“It has been reported that ASCs can fuse with endometrial cancer cells, and the fused endometrial cancer cells present a fibroblast-like appearance of mesenchymal phenotype accompanied by downregulation of E-cadherin expression and upregulation of Vimentin expression (40).”
BackgroundSelf-citationCirculating Adiponectin and Risk of Endometrial Cancer
Zheng, Q., Wu, H., & Cao, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129824 · Cited by 20 · cited 2×
“The decrease in serum adiponectin levels in obese patients is closely related to the increased risk of endometrial cancer (44).”
BackgroundEstrogen and high-fat diet induced alterations in C57BL/6 mice endometrial transcriptome profile
Cheng, Y., Lv, Q., Xie, B., Yang, B., Shan, W., Ning, C., Li, B., Xie, L., Gu, C., Luo, X., et al. (2017) · Endocrine Connections · doi:10.1530/ec-17-0315 · Cited by 20 · cited 1×
“The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), peroxisome proliferator activated receptor (PPAR) and LXR/RXR signaling pathways may be involved in this process (30).”
BackgroundArthur, R., Møller, H., Garmo, H., Häggström, C., Holmberg, L., Stattin, P. E., Malmström, H., Lambe, M. P., Hammar, N., Walldius, G., et al. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1093-1 · Cited by 19 · cited 1×
“Dyslipidemia is closely related to the incidence of various cancers (113).”
BackgroundAdiponectin, Leptin, and Insulin-Pathway Receptors as Endometrial Cancer Subtyping Markers
Busch, E. L., Crous‐Bou, M., Prescott, J., Downing, M. J., ROSNER, B. A., Mutter, G. L., & Vivo, I. D. (2018) · Hormones and Cancer · doi:10.1007/s12672-017-0318-1 · Cited by 18 · cited 1×
“typing markers have been found for endometrial cancer (127).”
BackgroundAdipocytokine Levels in Children: Effects of Fatness and Training
Aggeloussi, S., Theodorou, A. A., Paschalis, V., Nikolaidis, M. G., Fatouros, I. G., Owolabi, E., Kouretas, D., Koutedakis, Y., & Jamurtas, A. Z. (2012) · Pediatric Exercise Science · doi:10.1123/pes.24.3.461 · Cited by 17
Clinical significance of serum adiponectin and visfatin levels in endometrial cancer
Wang, Z.-M., Gao, S., Sun, C., Li, J., Gao, W., & Yu, L. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12772 · Cited by 16 · cited 1×
“The visfatin:adiponectin ratio in the endometrial cancer was significantly higher than the control, which has certain reference value for the diagnosis of endometrial cancer (56).”
BackgroundHigh prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer
Kitson, S., Lindsay, J., Sivalingam, V. N., Rutter, M. K., & Crosbie, E. J. (2018) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2018.08.006 · Cited by 15 · cited 1×
“A new research reported that there was a very high prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer (12).”
BackgroundZangooei, M., Nourbakhsh, M., Ghahremani, M. H., Meshkani, R., Khedri, A., Shadboorestan, A., Afra, H. S., Shahmohamadnejad, S., Mirmiranpour, H., & Khaghani, S. (2018) · EXCLI journal · doi:10.17179/excli2018-1299 · Cited by 14 · cited 1×
“Exogenous visfatin can promote the proliferation of breast cancer cells by promoting ERα phosphorylation and activating estrogen response element (ERE)-dependent signaling pathways (60).”
BackgroundOncogenic role of ABHD5 in endometrial cancer
Zhou, Q., Wang, F., Zhou, K., Huang, K., Zhu, Q., Luo, X., Yu, J., & Shi, Z. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188648 · Cited by 14 · cited 1×
“Previous studies have confirmed that elevated serum glucose can directly regulate cancer-related signaling pathways, especially to meet the needs of rapid proliferation of cancer cells, and can promote the process of glycometabolism reprogramming (91).”
BackgroundKu, S.-C., Ho, P., Tseng, Y., Yeh, T., Cheng, S.-L., & Liang, C. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.05.02.1 · Cited by 10 · cited 1×
“In addition, studies have reported that 11 cancer markers in overweight patients are significantly higher than those in normal weight patients, including ANG-2, sFASL, HB-EGF, IL-8, PLGF, TGF-α, TNF-α, uPA, VEGF-A, VEGF-C, and VEGF-D (77).”
Background
Metadata
- Authors
- Yang, X., & Wang, J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-08-08
- Volume
- 9
- Pages
- 744-744
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2963222754
- Cited by
- 159
- References
- 119
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.